Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,773 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Abscinazole-F1, a conformationally restricted analogue of the plant growth retardant uniconazole and an inhibitor of ABA 8'-hydroxylase CYP707A with no growth-retardant effect.
Todoroki Y, Kobayashi K, Shirakura M, Aoyama H, Takatori K, Nimitkeatkai H, Jin MH, Hiramatsu S, Ueno K, Kondo S, Mizutani M, Hirai N. Todoroki Y, et al. Among authors: kobayashi k. Bioorg Med Chem. 2009 Sep 15;17(18):6620-30. doi: 10.1016/j.bmc.2009.07.070. Epub 2009 Aug 3. Bioorg Med Chem. 2009. PMID: 19699646
Surface Tension of Biological Polyelectrolyte Solutions.
Okubo T, Kobayashi K. Okubo T, et al. Among authors: kobayashi k. J Colloid Interface Sci. 1998 Sep 15;205(2):433-442. doi: 10.1006/jcis.1998.5632. J Colloid Interface Sci. 1998. PMID: 9735207
Abiotic synthesis of guanine with high-temperature plasma.
Miyakawa S, Murasawa K, Kobayashi K, Sawaoka AB. Miyakawa S, et al. Among authors: kobayashi k. Orig Life Evol Biosph. 2000 Dec;30(6):557-66. doi: 10.1023/a:1026587607264. Orig Life Evol Biosph. 2000. PMID: 11196576
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations.
Kaneko S, Takasawa K, Asada K, Shiraishi K, Ikawa N, Machino H, Shinkai N, Matsuda M, Masuda M, Adachi S, Takahashi S, Kobayashi K, Kouno N, Bolatkan A, Komatsu M, Yamada M, Miyake M, Watanabe H, Tateishi A, Mizuno T, Okubo Y, Mukai M, Yoshida T, Yoshida Y, Horinouchi H, Watanabe SI, Ohe Y, Yatabe Y, Saloura V, Kohno T, Hamamoto R. Kaneko S, et al. Among authors: kobayashi k. Mol Cancer. 2024 Jun 11;23(1):126. doi: 10.1186/s12943-024-02035-6. Mol Cancer. 2024. PMID: 38862995
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).
Kobayashi K, Ogasawara S, Itobayashi E, Okubo T, Itokawa N, Nakamura K, Moriguchi M, Watanabe S, Ikeda M, Kuroda H, Kawaoka T, Hiraoka A, Yasui Y, Kuzuya T, Sato R, Kanzaki H, Koroki K, Inoue M, Nakamura M, Kiyono S, Kanogawa N, Kondo T, Nakamoto S, Ozawa Y, Tsuchiya K, Atsukawa M, Aikata H, Aramaki T, Oka S, Morimoto N, Kurosaki M, Itoh Y, Izumi N, Kato N. Kobayashi K, et al. Invest New Drugs. 2024 Jun 6. doi: 10.1007/s10637-024-01441-3. Online ahead of print. Invest New Drugs. 2024. PMID: 38842657
11,773 results
You have reached the last available page of results. Please see the User Guide for more information.